SCIENMAG: Medicine & Health

JANUARY 16, 2024

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

Virus 93

Virus Hospitals 93

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. The role of extracellular vesicles in COVID-19 virus infection [Internet]. Available from: [link]

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

The Pharma Data

OCTOBER 26, 2020

27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” SAN JOSE, Calif. , AR-711 (COVID-19). AR-201 (RSV infection). AR-201 (RSV infection).

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

NOVEMBER 13, 2020

A new survey shows one in five cancer patients are far less likely to participate in future clinical trials due to fear of COVID-19 exposure, raising the question of whether enrollment levels that have dropped precipitously since the beginning of the pandemic are likely to recover after the virus is controlled. percent since March 15.

Trials 52

Trials Clinical Trials Virus Research 52

The Pharma Data

OCTOBER 29, 2020

29, 2020– Alexion Pharmaceuticals, Inc. NASDAQ:ALXN) today announced financial results for the third quarter of 2020. Non-GAAP diluted EPS for the third quarter of 2020 was $3.24 , a 16 percent increase versus the third quarter of 2019. ” Third Quarter 2020 Financial Highlights. in the prior year.

Clinical Trials 40

Clinical Trials Trials Production Licensing 40

The Pharma Data

OCTOBER 21, 2020

22, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. The offering is expected to close on October 26, 2020, subject to the satisfaction of customary closing conditions. BOSTON, Oct. Morgan Securities LLC, SVB Leerink LLC and Barclays Capital Inc. are acting as joint book-running managers for the offering.

Immune Response 40

Immune Response Clinical Trials Therapies Production 40

The Pharma Data

MAY 6, 2021

This donation of the vaccine is another tool in our toolbox of measures to help make the Olympic and Paralympic Games Tokyo 2020 safe and secure for all participants and to show solidarity with our gracious Japanese hosts,” said IOC President Thomas Bach. “We This press release features multimedia. View the full release here: [link].

Vaccine 52

Vaccine Clinical Trials Licensing Licensing 52

The Pharma Data

NOVEMBER 10, 2020

S is derived from a common cold virus that is modified to carry a gene from the SARS-CoV-2 virus which causes COVID-19, prompting the immune system to develop resistance to the virus.

Vaccine 40

Vaccine Trials Clinical Trials Virus 40

NIH Director's Blog: Drug Discovery

NOVEMBER 5, 2020

Because SARS-CoV-2 is so highly infectious, basic researchers without access to specially designed biosafety facilities may be limited in their ability to study the virus. While the quantum dots may bind and enter human cells just like the virus, they can’t cause an infection. 2020 Sep 22;14(9):12234-12247.

Research Laboratories 85

Research Laboratories Laboratories Science Drugs 85

The Pharma Data

JANUARY 6, 2021

The announcement, following a $98 million IPO in October 2020, comes as the company advances several programs through its pipeline. In addition to its lead program, which began Phase I testing in 2020, the company expects to nominate three clinical candidates in 2021.

Virus 52

Virus FDA Approval Clinical Trials Trials 52

The Pharma Data

DECEMBER 9, 2020

10, 2020 04:32 UTC. The offering is expected to close on or about December 14, 2020, subject to satisfaction of customary closing conditions. Rocket’s first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition. Forward-looking Statements.

Pharmaceuticals 40

Pharmaceuticals Clinical Trials Therapies Trials 40

The Pharma Data

DECEMBER 16, 2020

16, 2020 — A World Health Organization team of experts will examine samples and medical data from China to try to find out where the new coronavirus first made the leap from animals to people. © 2020 HealthDay. . © 2020 HealthDay. Posted: December 2020. WHO Team Seeks to Pinpoint Source of COVID-19. WEDNESDAY, Dec.

Virus 52

Virus Disease 52

The Pharma Data

DECEMBER 23, 2020

23, 2020 — A COVID-19 outbreak in Antarctica means that the new coronavirus is now spreading on every continent. Until then, Antarctica had been the only continent that was free of the virus, CNN reported. © 2020 HealthDay. Posted: December 2020. WEDNESDAY, Dec. CNN Article. All rights reserved. More News Resources.

Virus 52

Virus Research 52

The Pharma Data

DECEMBER 15, 2020

15, 2020 — The U.S. Preventive Services Task Force (USPSTF) concludes that screening adults and adolescents at increased risk for hepatitis B virus (HBV) infection has moderate net benefit. © 2020 HealthDay. Posted: December 2020. Professional. USPSTF Recommends Hep B Screen for At-Risk Teens, Adults. TUESDAY, Dec.

Virus 52

Virus Therapies Trials Treatment 52

The Pharma Data

DECEMBER 17, 2020

17, 2020 — As a rule, COVID-19 spreads rapidly in most groups, but new research suggests that schools and day care centers appear to be the exception. ” But for schools to be safe, they need a lot of help, support and equipment to keep the virus from spreading, Hobbs said. © 2020 HealthDay. . © 2020 HealthDay.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

OCTOBER 27, 2020

27, 2020 — The tiny droplets that linger in the air after people talk, cough or sneeze aren’t very efficient at spreading the new coronavirus , new research suggests. © 2020 HealthDay. Posted: October 2020. TUESDAY, Oct. It is even lower if that person was only talking. And wash your hands.” Source link.

Virus 52

Virus Research 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 — Travelers flying to the United States from the United Kingdom will now need a negative COVID-19 test no more than 72 hours before leaving Britain, the U.S. The test is needed to guard against the spread of a new form of the virus found in the United Kingdom that may be 70 percent more contagious than other forms of COVID-19.

Virus 52

Virus Disease 52

The Pharma Data

NOVEMBER 18, 2020

18, 2020 — The Ebola outbreak in the Democratic Republic of the Congo (DRC) is over, health officials say. © 2020 HealthDay. Posted: November 2020. Ebola Outbreak in Democratic Republic of the Congo Declared Over. WEDNESDAY, Nov. More Information. All rights reserved. More News Resources. Subscribe to our Newsletter.

Virus 52

Virus Disease 52

The Pharma Data

DECEMBER 23, 2020

While the overall understanding of the condition is as novel as the virus that causes it, a recent survey from the U.K.’s This is proving very difficult, however, for the ever-expanding group of people dealing with the chronic and debilitating symptoms of what is commonly being called “Long Haul COVID” or “Long COVID.”.

Clinical Trials 52

Clinical Trials FDA Small Molecule Trials 52

The Pharma Data

JUNE 25, 2021

The outcome confirms that only one single case was attributable to the original SARS-CoV-2 virus. “In addition, the variant-rich environment underlines the importance of developing next-generation vaccines as new virus variants continue to emerge.” More than half of the cases (57%) were caused by Variants of Concern.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

NOVEMBER 23, 2020

23, 2020 — On Monday, AstraZeneca announced that late-stage clinical trials of its COVID-19 vaccine showed it to be 70.4 © 2020 HealthDay. Posted: November 2020. Professional. Third COVID-19 Vaccine Shows Effectiveness. MONDAY, Nov. percent effective, The New York Times reported. The New York Times Article.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

OCTOBER 23, 2020

ANESTHESIOLOGY 2020. The authors evaluated COVID-19 testing results (using a polymerase chain reaction [PCR] test and a verbal screening method) performed prior to anesthesia procedures among 1,033 children between March 26 and May 11, 2020. © 2020 HealthDay. Posted: October 2020. ” Press Release. . THURSDAY, Oct.

Virus 52

Virus Medical Schools Hospitals Research 52

Molecular Design

AUGUST 9, 2020

> I sometimes wonder what percentage of the pharmacopoeia will have been proposed for repurposing for the treatment of COVID19 by the end of 2020. There are three general approaches to directly tackle a virus such as SARS-CoV-2 with a small molecule drug (or chemical agent).

Drugs 52

Drugs Virus Small Molecule Treatment 52

The Pharma Data

DECEMBER 2, 2020

3, 2020 09:00 UTC. MTX-COVAB was also found to have virus neutralizing potency (IC50= 40pM), which is comparable or better to that of the leading antibody therapies in development, and cross-neutralizes all clinically relevant virus mutants. About Memo Therapeutics AG.

Disease 52

Disease Virus Treatment Therapies 52

The Pharma Data

OCTOBER 28, 2020

28, 2020 /PRNewswire/ — . In the overall patient group with detectable virus at baseline, the average daily reduction in viral load through day 7 was a 0.36 Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2019 and its Form 10-Q for the quarterly period ended June 30, 2020.

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

DECEMBER 14, 2020

Date: 7 December 2020 . WHO-identifier: 2020/5, version 1. The design principle of RT-PCR means that for patients with high levels of circulating virus (viral load), relatively few cycles will be needed to detect virus and so the Ct value will be low.

Virus 52

Virus Production Regulations 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 — The World Health Organization says steps to expand genome sequencing of new variants of the coronavirus are needed as the pandemic enters its second year, the Associated Press reported. © 2020 HealthDay. Posted: December 2020. Professional. WHO Calls for New Measures to Identify COVID-19 Variants. MONDAY, Dec.

Virus 52

Virus 52

The Pharma Data

NOVEMBER 10, 2020

He said the company will potentially supply 76 million doses of the plant-based vaccine, which uses noninfectious virus-like particles to mimic the coronavirus in order to induce an immune response. The interim analysis from the phase 1 trial has been published online at the preprint server, medRxiv. Martin Berman-Gorvine.

Immune Response 40

Immune Response Vaccine Clinical Trials Virus 40

The Pharma Data

DECEMBER 23, 2020

23, 2020 — Keep your distance. “A mask definitely helps, but if the people are very close to each other, there is still a chance of spreading or contracting the virus,” said study co-author Krishna Kota, an associate professor of mechanical and aerospace engineering. © 2020 HealthDay. Posted: December 2020.

Virus 52

Virus Engineering Research 52

The Pharma Data

OCTOBER 15, 2020

15, 2020 — A single pick-up hockey game in Tampa Bay in June wound up becoming a COVID-19 superspreader event, with one player infecting as many as 15 other people on the ice, Florida public health officials report. © 2020 HealthDay. Posted: October 2020. THURSDAY, Oct. The other two sick people were not tested for COVID.

Virus 52

Virus Disease 52

The Pharma Data

OCTOBER 19, 2020

19, 2020 — The U.S. emergency sick leave provision was a highly effective policy tool to flatten the curve in the short-run , it only contains up to two weeks of paid sick leave and is set to expire at the end of 2020,” the authors write. © 2020 HealthDay. .” © 2020 HealthDay. Posted: October 2020.

Virus 52

Virus Treatment Research 52

The Pharma Data

DECEMBER 18, 2020

18, 2020 — Recipients of kidneys from donors infected with hepatitis C virus (HCV) have similar kidney allograft function and probability of rejection in the first year after transplantation as those who receive kidneys from donors without HCV infection, according to a study published online Dec. © 2020 HealthDay.

Virus 52

Virus Science Pharmaceuticals Disease 52

The Pharma Data

DECEMBER 15, 2020

15, 2020 — The first nonprescription COVID-19 test that enables people to collect samples and get results at home has received emergency use authorization from the U.S. © 2020 HealthDay. Posted: December 2020. Professional. FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19. TUESDAY, Dec.

FDA Approval 52

FDA Approval FDA Virus Drugs 52

The Pharma Data

DECEMBER 7, 2020

7, 2020 — For women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, rooming-in and breastfeeding are feasible for those who can care for their infants, with postnatal transmission occurring infrequently, according to a study published online Dec. © 2020 HealthDay. Posted: December 2020.

Virus 52

Virus Research 52

The Pharma Data

NOVEMBER 17, 2020

17, 2020 — From 2009 to 2018, there were increases in diseases-of-despair diagnoses, according to a study published online Nov. © 2020 HealthDay. Posted: November 2020. TUESDAY, Nov. 9 in BM J Open. Emily Brignone, Ph.D., Abstract/Full Text. All rights reserved. Source link.

Disease 52

Disease Virus Research Drugs 52

The Pharma Data

JULY 28, 2021

The analysis included 945,941 mRNA participants (778,534 with two doses), 426,272 Vaxzevria participants, conducted between 27 December 2020 and 19 May 2021. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.

Vaccine 52

Vaccine Virus Science Disease 52

The Pharma Data

SEPTEMBER 8, 2021

The two companies have collaborated for more than 20 years to rapidly address critical healthcare needs including biological threats, such as SARS, anthrax, avian influenza virus H5N1, MERS, the novel influenza virus H1N1 swine, Ebola virus, Zika virus and most recently, SARS-CoV-2 virus and its variants.

Virus 52

Virus Assay Development Disease Research 52